M
M.-L. Welter
Publications - 10
Citations - 990
M.-L. Welter is an academic researcher. The author has contributed to research in topics: Subthalamic nucleus & Parkinson's disease. The author has an hindex of 7, co-authored 10 publications receiving 948 citations.
Papers
More filters
Journal ArticleDOI
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial.
W. M. M. Schüpbach,David Maltête,Jean-Luc Houeto,S. Tezenas du Montcel,Luc Mallet,M.-L. Welter,M. Gargiulo,C. Béhar,A. M. Bonnet,Virginie Czernecki,Bernard Pidoux,Soledad Navarro,Didier Dormont,P. Cornu,Yves Agid +14 more
TL;DR: Subthalamic nucleus stimulation should be considered a therapeutic option early in the course of Parkinson disease, and quality of life was improved by 24% in surgical and 0% in nonsurgical patients.
Journal Article
Neurosurgery in Parkinson disease : A distressed mind in a repaired body? Authors' reply
Mazen Jabre,Boulos-Paul Bejjani,Yves Agid,Michael Schüpbach,M. Gargiulo,M.-L. Welter,Luc Mallet,C. Béhar,J.-L. Houeto,David Maltête,Valérie Mesnage +10 more
Journal Article
Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up. Authors' reply
Anthony E. Lang,Galit Kleiner-Fisman,Jean A. Saint-Cyr,Janis M. Miyasaki,Andres M. Lozano,J.-L. Houeto,Valérie Mesnage,M.-L. Welter,Luc Mallet,Yves Agid,B. P. Bejjani,Alexandre Berney,J. Ghika,J.G. Villemure,Fjg. Vingerhoets +14 more
TL;DR: By optimizing stimulation parameters of PD patients who underwent subthalamic nucleus (STN) deep brain stimulation (DBS), Vingerhoets et al.1 minimized the amount of antiparkinsonian medication required, maintaining many study patients off medication, with potential harmful consequences.
Journal ArticleDOI
Parkinson’s disease with camptocormia
Frédéric Bloch,J. L. Houeto,S. Tezenas du Montcel,Fabrice Bonneville,Fabien Etchepare,M.-L. Welter,Sophie Rivaud-Péchoux,Valérie Hahn-Barma,Thierry Maisonobe,C. Béhar,J. Y. Lazennec,Ewa Kurys,Isabelle Arnulf,Anne-Marie Bonnet,Yves Agid +14 more
TL;DR: Patients with camptocormia were characterised by prominent levodopa-unresponsive axial symptoms (ie, axial rigidity, gait disorder and postural instability), along with a tendency for greater error in the antisaccade paradigm, and it is suggested that the salient features of parkinsonism observed in patients with camps are likely to represent a specific form of Parkinson’s disease.
Journal ArticleDOI
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease
Valérie Fraix,J.-L. Houeto,Christelle Lagrange,C. Le Pen,Pierre Krystkowiak,Dominique Guehl,Claire Ardouin,M.-L. Welter,F Maurel,Luc Defebvre,Alain Rougier,A-L Benabid,Valérie Mesnage,M Ligier,Serge Blond,Pierre Burbaud,Bernard Bioulac,Alain Destée,P. Cornu,Pierre Pollak +19 more
TL;DR: STN stimulation has good outcomes with relatively low risk and little cost burden in PD patients with levodopa induced motor complications, and its effects over 12 months are assessed.